SEC Company Response from Predictive Oncology Inc. (AGPU) (CIK 0001446159) (AGPU) — Aug 24, 2015
Predictive Oncology Inc. (AGPU) (CIK 0001446159)
Date: Aug. 24, 2015 · CIK: 0001446159 · Accession: 0001214659-15-006250
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-198962
Letter
VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Attention: Mr. Jay Mumford Re: Skyline Medical Inc. Registration Statement on Form S-1 File No. 333-198962
Dear Mr. Mumford:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned, as underwriter of the proposed offering, hereby joins the request of Skyline Medical Inc. that the effective date of the above-referenced Registration Statement on Form S-1 be declared effective at 4:30 p.m. (Washington, D.C. time) on Tuesday, August 25, 2015, or as soon as practicable thereafter.
In connection with the proposed offering of the Company’s securities, copies of the preliminary prospectuses dated August 10, 2015 were distributed to the following persons in the following approximate amounts:
To Whom Distributed
Number of Copies
Institutions
Syndicate
Individuals
Total
We have complied and will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Sincerely,
Dawson James Securities, Inc.
Show Raw Text
CORRESP
1
filename1.htm
d818150corresp.htm
August 24, 2015
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Mr. Jay Mumford
Re:
Skyline Medical Inc.
Registration Statement on Form S-1
File No. 333-198962
Dear Mr. Mumford:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned, as underwriter of the proposed offering, hereby joins the request of Skyline Medical Inc. that the effective date of the above-referenced Registration Statement on Form S-1 be declared effective at 4:30 p.m. (Washington, D.C. time) on Tuesday, August 25, 2015, or as soon as practicable thereafter.
In connection with the proposed offering of the Company’s securities, copies of the preliminary prospectuses dated August 10, 2015 were distributed to the following persons in the following approximate amounts:
To Whom Distributed
Number of Copies
Institutions
16
Syndicate
6
Individuals
868
Total
890
We have complied and will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Sincerely,
Dawson James Securities, Inc.
By:
/s/ Robert D. Keyser, Jr.
Name
Robert D. Keyser, Jr.
Title
Chief Executive Officer